Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Liver Diseases Therapeutics Market Size During 2025–2029?
The liver diseases therapeutics market size has experienced strong growth in recent years. It is projected to expand from $14.16 billion in 2024 to $15.18 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.2%. The historical increase in this market can be attributed to the high prevalence of liver diseases, patterns of alcohol consumption, advancements in diagnostics, the rise of obesity and metabolic syndrome, the implementation of awareness and screening programs, and government initiatives for hepatitis control.
The liver diseases therapeutics market size is anticipated to undergo robust expansion in the coming years. This market is expected to reach $22.08 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.8%. The projected growth during this period can be ascribed to factors like precision medicine approaches, innovations in RNA therapeutics, a concentrated focus on fibrosis treatments, the influence of patient advocacy and support groups, the development of vaccines for hepatitis, and regulatory support for orphan drugs. Key trends foreseen in the forecast period include advancements in the treatment of hepatitis C, the emergence of novel therapies for liver fibrosis, the exploration of immunotherapies, the adoption of telemedicine and remote monitoring, and an increased emphasis on nutritional interventions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Liver Diseases Therapeutics Industry?
The escalating occurrence of liver diseases is anticipated to propel the expansion of the liver disease therapeutics market in the foreseeable future. Liver disease refers to any condition that affects the liver, and liver disease therapeutics are designed to help treat these conditions through various methods. For instance, in April 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, data from 2022 showed that the mortality rate from liver disease among individuals under 75 years old in England rose to 21.4 per 100,000 population. During this period, males experienced 6,664 premature deaths, compared to 3,929 for females. Consequently, the rising prevalence of liver diseases is a key factor driving the growth of the liver disease therapeutics market.
Which Key Segments Fueling The Liver Diseases Therapeutics Market?
The liver diseases therapeuticsmarket covered in this report is segmented –
1) By Disease Type: Hepatitis; Non-Alcoholic Fatty Liver Disease; Alcohol-Induced; Liver Cancer
2) By Treatment: Antiviral; Vaccines; Chemotherapy; Immunosuppressive Agents; Corticosteroids
3) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users
Subsegments:
1) By Hepatitis: Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D
2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH); Simple Fatty Liver
3) By Alcohol-Induced Liver Disease: Alcoholic Hepatitis; Alcoholic Cirrhosis
4) By Liver Cancer: Hepatocellular Carcinoma (HCC); Cholangiocarcinoma
Which Market Trends Are Creating New Opportunities In The Liver Diseases Therapeutics Industry?
Strategic partnerships are a prominent trend gaining traction in the liver disease therapeutics market. Key companies active in the liver diseases therapeutics market are engaging in collaborations to bolster their presence within the sector. For example, in January 2022, Aligos Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, teamed up with Merck & Co, a US-based company involved in liver disease therapeutics. This partnership aims to discover and develop oligonucleotide therapies for non-alcoholic steatohepatitis.
Which Global Market Leaders Are Shaping The Future Of The Liver Diseases Therapeutics Sector?
Major companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals, Watson Pharmaceuticals Inc., AstraZeneca PLC, Gilead Sciences Inc., Endo International PLC, Alnylam Pharmaceuticals Inc., Provectus Biopharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
How Is Liver Diseases Therapeutics Market Demand Varying Across Different Regions?
North America was the largest region in the liver diseases therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in the liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Liver Diseases Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=7969&type=smp
Browse Through More Reports Similar to the Global Liver Diseases Therapeutics Market 2025, By The Business Research Company
Digital Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report
Antisense And Rnai Therapeutics Global Market Report 2025
Transplant Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model